Covance To Open Its Own Preclinical Facility In Shanghai After Abandoning Plans To Create Joint Drug Testing Facility With WuXi

SHANGHAI - Princeton-headquartered contact research organization Covance is investing $20-25 million to build a preclinical laboratory in Shanghai, the company's second such research facility in Shanghai